- Home
- VYX vs TVTX Comparison
VYX vs TVTX Comparison
Compare VYX & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYX
- TVTX
- Stock Information
- Founded
- VYX 1881
- TVTX 2008
- Country
- VYX United States
- TVTX United States
- Employees
- VYX N/A
- TVTX N/A
- Industry
- VYX
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- VYX
- TVTX Health Care
- Exchange
- VYX Nasdaq
- TVTX Nasdaq
- Market Cap
- VYX 1.1B
- TVTX 1.3B
- IPO Year
- VYX N/A
- TVTX N/A
- Fundamental
- Price
- VYX $7.80
- TVTX $14.92
- Analyst Decision
- VYX Strong Buy
- TVTX Strong Buy
- Analyst Count
- VYX 6
- TVTX 13
- Target Price
- VYX $15.17
- TVTX $33.75
- AVG Volume (30 Days)
- VYX 2.4M
- TVTX 2.0M
- Earning Date
- VYX 05-08-2025
- TVTX 05-05-2025
- Dividend Yield
- VYX N/A
- TVTX N/A
- EPS Growth
- VYX N/A
- TVTX N/A
- EPS
- VYX 6.52
- TVTX N/A
- Revenue
- VYX $2,826,000,000.00
- TVTX $233,175,000.00
- Revenue This Year
- VYX N/A
- TVTX $68.31
- Revenue Next Year
- VYX N/A
- TVTX $55.65
- P/E Ratio
- VYX $1.15
- TVTX N/A
- Revenue Growth
- VYX N/A
- TVTX 60.55
- 52 Week Low
- VYX $7.67
- TVTX $5.12
- 52 Week High
- VYX $15.34
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- VYX 32.33
- TVTX 37.07
- Support Level
- VYX $7.74
- TVTX $14.13
- Resistance Level
- VYX $8.48
- TVTX $15.23
- Average True Range (ATR)
- VYX 0.56
- TVTX 1.31
- MACD
- VYX -0.05
- TVTX -0.10
- Stochastic Oscillator
- VYX 5.70
- TVTX 31.70
About VYX NCR Voyix Corporation
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.